However, growing understanding using evolved computational in-silico analyses and their significant role in several human diseases such as obesity, diabetes, IBD, and aging, FFAR2/3 are emerging as potential therapeutic targets [117,118]. The gene discussed is FFAR2; the disease is inflammatory bowel disease.